XML 36 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
OPERATING ACTIVITIES:          
Net income $ 517 $ 215 $ 294 $ 646  
Adjustments to net income:          
Depreciation, amortization, and accretion of AROs 365 312 1,056 945 $ 945
Gain (loss) on disposal and sale of business interests (1) 1 (70) (43)  
Asset Impairment Charges     (32) 158  
Deferred income tax expense (benefit), net of tax credit transfers allocated to AES     402 423  
Tax credit transfer proceeds allocated to noncontrolling interests     568 178  
Sales-type Lease, Selling Profit (Loss) 13 0 221 67  
Emissions Allowance Expense     241 144  
Loss on realized/unrealized foreign currency     35 92  
Other     268 (183)  
Changes in operating assets and liabilities:          
(Increase) decrease in accounts receivable     (16) (576)  
(Increase) decrease in inventory     10 58  
(Increase) decrease in prepaid expenses and other current assets     (24) 120  
(Increase) decrease in other assets     63 177  
Increase (decrease) in accounts payable and other current liabilities     147 34  
Increase (decrease) in income tax payables, net and other tax payables     (484) (514)  
Increase (decrease) in other liabilities     90 132  
Net cash provided by operating activities     2,818 1,664  
INVESTING ACTIVITIES:          
Capital expenditures     (4,394) (5,665)  
Payments to Acquire Businesses and Interest in Affiliates     104 79  
Proceeds from Divestiture of Businesses and Interests in Affiliates     105 11  
Sale of short-term investments     70 731  
Purchase of short-term investments     (57) (725)  
Contributions and loans to equity affiliates     (2) (71)  
Payments to Acquire Intangible Assets     (260) (157)  
Other investing     24 (134)  
Net cash used in investing activities     (4,618) (6,089)  
FINANCING ACTIVITIES:          
Borrowings under the revolving credit facilities     2,711 5,652  
Repayments under the revolving credit facilities     (3,951) (4,051)  
Proceeds from (Repayments of) Commercial Paper     643 611  
Issuance of recourse debt     800 950  
Repayments of recourse debt     (898) 0  
Issuance of non-recourse debt     4,397 5,199  
Repayments of non-recourse debt     (2,523) (3,311)  
Payments for financing fees     (101) (88)  
Purchases under supplier financing arrangements     (1,237) (1,211)  
Repayments of obligations under supplier financing arrangements     1,108 1,412  
Distributions to noncontrolling interests     (523) (165)  
Acquisitions of noncontrolling interests     (143) 0  
Contributions from noncontrolling interests     337 137  
Sales to Noncontrolling Interests     1,289 869  
Issuance of Preferred Shares in Subsidiaries     528 0  
Dividends paid on AES common stock     (376) (361)  
Payments for financed capital expenditures     (28) (29)  
Other financing     (38) (25)  
Net cash provided by financing activities     2,253 5,187  
Effect of exchange rate changes on cash, cash equivalents and restricted cash     (22) (47)  
Net Cash Change Of Discontinued And Held For Sale Businesses     79 (146)  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect     510 569  
Cash, cash equivalents and restricted cash, beginning     2,039 1,990 1,990
Cash, cash equivalents and restricted cash, ending 2,549 2,559 2,549 2,559 2,039
SUPPLEMENTAL DISCLOSURES:          
Cash payments for interest, net of amounts capitalized     859 1,103  
Cash payments for income taxes, net of refunds     192 270  
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:          
Noncash or Part Noncash Divestiture, Amount of Consideration Received     19 14  
Lease Obligation Incurred     155 240  
Noncash distributions to noncontrolling interests     193 0  
Conversion of Stock, Amount Converted     0 838  
Liability derecognized due to sale of assets 0 $ 273 0 273  
Non-cash contributions from noncontrolling interests     610 213  
Other current assets, net of allowance of $2 and $0, respectively 1,781   1,781   $ 1,612
Loss (gain) on realized/unrealized derivatives     49 $ (194)  
Warrior Run          
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:          
Liability derecognized due to sale of assets $ 260   $ 260